Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / LGALS8

LGALS8

Basics

Aliases:
This biomarker is also known as:
  • Gal-8,
  • galectin-8,
  • lectin, galactoside-binding, soluble, 8,
  • Po66 carbohydrate-binding protein,
  • Po66 carbohydrate binding protein,
  • galectin 8,
  • prostate carcinoma tumor antigen 1,
  • PCTA-1,
  • PCTA1,
  • galectin-8g,
  • Po66-CBP,
  • Prostate carcinoma tumor antigen 1,
  • po66 carbohydrate-binding protein,

Description…

lectin, galactoside-binding, soluble, 8

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: LGALS8

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Biomuta

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.